Common Stock, Shares, Outstanding of AVAI BIO, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AVAI BIO, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • AVAI BIO, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 138,031,533, a 0.66% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 138,031,533 +899,953 +0.66% 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 137,829,465 +5,957,023 +4.5% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 137,511,233 +20,493,327 +18% 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q1 2025 137,363,513 +20,195,607 +17% 31 Mar 2025 10-Q 12 Feb 2026 2026 Q3
Q4 2024 137,131,580 +52,337,202 +62% 31 Dec 2024 10-Q 07 Feb 2025 2025 Q3
Q3 2024 131,872,442 +67,368,631 +104% 30 Sep 2024 10-Q/A 21 Jan 2025 2025 Q2
Q2 2024 117,017,906 +52,514,095 +81% 30 Jun 2024 10-Q/A 21 Jan 2025 2025 Q1
Q1 2024 117,167,906 +78,664,095 +204% 31 Mar 2024 10-K 08 Jul 2025 2025 FY
Q4 2023 84,794,378 +52,563,295 +163% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 64,503,811 +32,272,728 +100% 30 Sep 2023 10-Q 17 Nov 2023 2024 Q2
Q2 2023 64,503,811 +38,187,728 +145% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q1
Q1 2023 38,503,811 +12,187,728 +46% 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q4 2022 32,231,083 +5,915,000 +22% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 32,231,083 +5,915,000 +22% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 26,316,083 +34,483 +0.13% 30 Jun 2022 10-Q 19 Aug 2022 2023 Q1
Q1 2022 26,316,083 +34,483 +0.13% 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q4 2021 26,316,083 +34,483 +0.13% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 26,316,083 +34,483 +0.13% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 26,281,600 0 0% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q1
Q1 2021 26,281,600 +25,217,520 +2370% 31 Mar 2021 10-Q 19 Aug 2022 2023 Q1
Q4 2020 26,281,600 +21,267,520 +424% 31 Dec 2020 10-Q 18 Feb 2021 2021 Q3
Q3 2020 26,281,600 +21,267,520 +424% 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 26,281,600 +21,267,520 +424% 30 Jun 2020 10-Q 14 Feb 2022 2022 Q3
Q1 2020 1,064,080 -3,950,000 -79% 31 Mar 2020 10-K 29 Jun 2022 2022 FY
Q4 2019 5,014,080 0 0% 31 Dec 2019 10-Q 04 Feb 2020 2020 Q3
Q3 2019 5,014,080 0 0% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q2
Q2 2019 5,014,080 +1,014,080 +25% 30 Jun 2019 10-Q/A 17 Oct 2019 2020 Q1
Q1 2019 5,014,080 +1,014,080 +25% 31 Mar 2019 10-K 13 Aug 2020 2020 FY
Q4 2018 5,014,080 31 Dec 2018 10-Q 17 Jan 2019 2019 Q3
Q3 2018 5,014,080 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 4,000,000 30 Jun 2018 10-Q 25 Jul 2018 2019 Q1
Q1 2018 4,000,000 31 Mar 2018 10-K 15 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.